Furosap Efficacy & Safety Conclusions

ASSESS THE EFFICACY OF FUROSAP^®, A TESTOSTERONE BOOSTER SUPPLEMENT, IN 50 HUMAN VOLUNTEERS: An Add-On Study at Saroj Hospital & Maternity Center, Lucknow

Efficacy Conclusions

1. Free testosterone levels are improved up to 46% in approx. 90% of the study population. Clinical Studies

2. The frequency of sexual intercourse is also an increase in 98% of the study population.

3. 85.4% of the study population showed improvement in the sperm count.

4. The abnormal sperm morphology also improved in 14.6% of the study population.

5. All patients enrolled in the study shows improvement in mental alertness and their mood.

6. The reflex erection was also enhanced in 95.2% of the study population.

7. The improvement in overall performance in all enrolled patients is observed.

Safety Conclusions

On completion of the study, the following safety conclusions were made:

1. No significant change in serum liver function tests is observed.

2. No significant change in cholesterol levels is observed.

3. No significant change in hemogram is observed.

ASSESS THE EFFICACY OF FUROSAP^®, A TESTOSTERONE BOOSTER SUPPLEMENT, IN 100 HUMAN VOLUNTEERS: AN ADD-ON STUDY at King George’s Medical University, Lucknow

Efficacy Conclusions

i. Frequency of sexual intercourse: A significant increase in frequency of sexual intercourse was observed in the study population after 12 weeks of complete treatment. 38.71% increase in the frequency of sexual intercourse is observe.

ii. Free testosterone levels: 88.6% of study population shows significant increase in free testosterone levels. On completion of thetreatment, 72.87% increase in free testosterone levels is observe in the patients.

iii. Total testosterone levels: On the other hand,total testosterone levels increased significantly up to 28.04% in the study population. These positive effects were seen in 85.02% of the study population.

iv. Sperm profile: The sperm profile greatly improved in the enrolled testosterone deficient patients. The sperm count is increase up to 34.82% in the study population. The sperm motility is also observed to be improved in 17.46% of the study population. Whereas, abnormal sperm morphology is efficiently decreased up to 18.81% in the study population.

v. Scoring chart: It is also observed that various parameters of scoring chart show improvements till the completion of the treatment. 81.8% of study population showed improvement in mental alertness, 95.5% of study population shows improvement in mood, 90.9% of study population shows improvement in reflex erection and 98.9% study population shows great improvement in overall performance till the completion of the treatment.

Safety conclusions

i. No significant change in the liver function tests (serum SGOT, SGPT & ALP activities) is observed.

ii. No significant change in BUN level is observed.

iii. No significant change in the hematological parameters is observed on completion of the treatment.

Any Query?

Hello!